Decision: Favourable
Study Title:
PIONEER IV trial: Non-inferiority of angiography-derived physiology guidance versus usual care in an All-comers population treated with unrestricted use of Healing-Targeted Supreme stent (HT Supreme) and P2Y12 inhibitor monotherapy after
NREC Code:
21-NREC-MD-003
Decision:
Favourable
Meeting Date:
24/06/2021
Study Type:
MD application
Principal Investigator:
Prof Patrick Serruys
PI Institution:
NUIG
Sponsor:
NUIG